Retinal OCT Can Act as Prognostic Biomarker of Kidney Injury

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, Dec. 11, 2023 -- Retinal optical coherence tomography (OCT) has potential to act as a noninvasive monitor and prognostic biomarker of kidney injury, according to a study published online Dec. 5 in Nature Communications.

Tariq E. Farrah, B.M., B.Sc., from the University of Edinburgh in the United Kingdom, and colleagues examined the potential of retinal OCT to track kidney injury, demonstrate treatment response, and predict outcomes in patients with predialysis chronic kidney disease (CKD), patients with kidney failure undergoing kidney transplantation, living kidney donors, and healthy volunteers.

The researchers identified similar retinal thinning and reduced macular volume in patients with CKD and those with a kidney transplant compared with healthy volunteers. The choroidal thinning seen in CKD was not seen in kidney transplant recipients whose choroids were similar to those of healthy volunteers. The degree of choroidal thinning in CKD was related to a reduced estimated glomerular filtration rate (eGFR) and the extent of kidney scarring. Choroidal thickness increased rapidly (~10 percent) following kidney transplantation and was maintained over one year; during the 12 months following kidney donation, gradual choroidal thinning was seen. Retinal and choroidal thickness was independently associated with eGFR decline over two years in patients with CKD.

"OCT metrics have already been incorporated into clinical trial outcome measures in multiple sclerosis and our data introduce the exciting possibility that these metrics might be included alongside eGFR and proteinuria to individualize cardiovascular risk and the risk of kidney disease progression in future trials in CKD," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-12 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords